Oral and Intra-nasal Administration of Nanoparticles in the Cerebral Ischemia Treatment in Animal Experiments: Considering its Advantages and Disadvantages
Open Access
- 5 May 2020
- journal article
- review article
- Published by Bentham Science Publishers Ltd. in Current Clinical Pharmacology
- Vol. 15 (1) , 20-29
Abstract
Background: Over the past few decades, nanotechnology has dramatically advanced; from the precise strategies of synthesizing modern nanostructures to methods of entry into the body. Using nanotechnology in diagnosis, drug delivery, determining signaling pathways, and tissue engineering is great hope for the treatment of stroke. The drug-carrying nanoparticles are a way to increase drug absorption through the mouth or nose in treating the stroke. Objective: In this article, in addition to explaining pros and cons of oral and intra-nasal administration of nanoparticles in the brain ischemia treatment of animal models, the researchers introduce some articles in this field and briefly mentioned their work outcomes. Methods: A number of relevant published articles 183 were initially collected from three popular databases including PubMed, Google Scholar, and Scopus. The articles not closely related to the main purpose of the present work were removed from the study process. The present data set finally included 125 published articles. Results: Direct delivery of the drug to the animal brain through the mouth and nose has more therapeutic effects than systemic delivery of drugs. The strategy of adding drugs to the nanoparticles complex can potentially improve the direct delivery of drugs to the CNS. Conclusion: Despite the limitations of oral and intra-nasal routes, the therapeutic potential of oral and intra-nasal administration of nano-medicines is high in cerebral ischemia treatment.Keywords
This publication has 117 references indexed in Scilit:
- Engineered nanomaterial uptake and tissue distribution: from cell to organismInternational Journal of Nanomedicine, 2013
- Neuroprotective Role of Nanoencapsulated Quercetin in Combating Ischemia-Reperfusion Induced Neuronal Damage in Young and Aged RatsPLOS ONE, 2013
- Core-shell hybrid liposomal vesicles loaded with panax notoginsenoside: preparation, characterization and protective effects on global cerebral ischemia/reperfusion injury and acute myocardial ischemia in ratsInternational Journal of Nanomedicine, 2012
- Cancer prevention by targeting angiogenesisNature Reviews Clinical Oncology, 2012
- Protective effect of Curcumin on chronic cerebral ischemia by altering expression of α- synuclein in 2VO modelMolecular Neurodegeneration, 2012
- Chemical Diversity of Panax ginseng, Panax quinquifolium, and Panax notoginsengJournal of Ginseng Research, 2012
- Targeting the Nrf2–Keap1 antioxidant defence pathway for neurovascular protection in strokeThe Journal of Physiology, 2011
- Physiologically Based Pharmacokinetic Modeling of NanoparticlesACS Nano, 2010
- Transferrin- and transferrin-receptor-antibody-modified nanoparticles enable drug delivery across the blood–brain barrier (BBB)European Journal of Pharmaceutics and Biopharmaceutics, 2009
- Effect of light and temperature on zeta potential and physical stability in solid lipid nanoparticle (SLN™) dispersionsInternational Journal of Pharmaceutics, 1998